EEG plays an important role in inclusion/exclusion criteria for safety and efficacy evaluations and as biomarkers in clinical trials. Given the heterogeneity of understanding of the strengths and the limitations of EEG in this context, we provide a brief commentary to inform drug sponsors, contract research organizations, and academic partners on some of the questions to consider.
Read More
Using EEG in the ED Emergency Departments (ED) of hospitals nationwide have seen significant increased visits over the last 20 years, with an even larger increase in adult and pediatric patients presenting with altered mental status (AMS). The role for EEG evaluation and monitoring in the ED is well documented, though in many facilities there […]
Read More
Reports from Wuhan and Lombardy early in this pandemic indicated that COVID-19 has a significant impact on the brain. In the acute period of SARS-CoV-2 infection, 34.6 % patients were observed to have neurological symptoms including stroke, headache, and seizures. Basic science studies on mechanism of viral entry and vascular involvement have corroborated these observations […]
Read More
Long-term EEG studies can take days or weeks to schedule and complete, and studies taking place in the Epilepsy Monitoring Unit (EMU) come with increased risk in today’s circumstances. The COVID-19 pandemic has tightened restrictions in hospitals everywhere. For many patients, (in particular, those who only require scalp EEGs and are not having their antiepileptic […]
Read MoreTelemedicine or telehealth has been described as a path to virtual integrated care and is changing health care delivery in communities across the United States (US). The use of telehealth in hospitals has grown rapidly from 35% in 2010 to 76% in 2017, connecting patients to vital health care services with consulting practitioners at a […]
Read MoreWith patients and potential patients across the country being advised to avoid hospitals and to cancel or delay elective procedures, telemedicine and other remote digital health services are being touted as alternative options. Unfortunately, some specialties are better suited than others for such an approach. And, as a result, some patients may be missing important diagnostic […]
Read MoreASET- The Neurodiagnostic Society Recently the American Society for Electrodiagnostic Technologists (ASET) published its recommendations on the appropriate infection control precautions to follow when providing needed diagnostic EEG procedures, assuming the presence of the SARS-CoV-2 virus causing the COVID-19 pandemic. We have a link below to the document. ASET has also made available, in pre-publication, […]
Read MoreRecently, the American Clinical Neurophysiology Society (ACNS) published a series of resources covering technologist safety, equipment cleaning, physician staffing and how to manage orders and requests for neurodiagnostic testing, including inpatient EEGs, elective monitoring of patients in the EMU and outpatient testing such as routine and ambulatory video-EEG studies. CortiCare has New EEG Solutions to […]
Read More
March 2020 New Challenges The COVID-19 pandemic has caused many clinicians and facilities to reassess priorities and the processes for delivering services. This is clearly true in the healthcare segments that CortiCare serves, namely the evaluation and monitoring of patients suspected or at risk for seizures or other brain function complications from chronic or acute […]
Read More
We want to emphasize to both adult and pediatric ICU providers that when patients present with severe respiratory compromise during the COVID-19 pandemic and are exhibiting impaired consciousness, brain monitoring may be in order.
Read More